‌

US Patent 10647698 Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders

Patent 10647698 was granted and assigned to Arvinas on May, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Arvinas

Current Assignee

Arvinas

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

106476980

Date of Patent

May 12, 2020

Patent Application Number

158295410

Date Filed

December 1, 2017

Patent Citations Received

‌

US Patent 11986532 Modulators of BCL6 proteolysis and associated methods of use

‌

US Patent 10899742 Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders

‌

US Patent 11597720 Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders

Patent Primary Examiner

‌

Matthew P Coughlin

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10647698 Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API